The Journal of Allergy and Clinical Immunology: In Practice
Clinical CommunicationsFood allergy at 1 year predicts persistence of eczema at 6 years
Section snippets
Acknowledgments
The HealthNuts study group is made up of the HealthNuts investigators, including Professor Melissa Wake, Professor Colin Robertson, and Professor Terry Dwyer. We thank the parents and children who participated in the HealthNuts study as well as the staff of Melbourne's Local Government Areas for access to community immunization clinics. We would also like to thank the HealthNuts safety committee: Associate Professor Noel Cranswick (Australian Paediatric Pharmacology Research Unit, Murdoch
References (9)
- et al.
Clinical phenotypes and endophenotypes of atopic dermatitis: where are we, and where should we go?
J Allergy Clin Immunol
(2017) - et al.
Mechanism for initiation of food allergy: dependence on skin barrier mutations and environmental allergen costimulation
J Allergy Clin Immunol
(2018) - et al.
The skin as a target for prevention of the atopic march
Ann Allergy Asthma Immunol
(2018) - et al.
Predetermined challenge eligibility and cessation criteria for oral food challenges in the HealthNuts population-based study of infants
J Allergy Clin Immunol
(2012)
Cited by (0)
This work was supported by funding from the National Health and Medical Research Council (NHMRC) of Australia, Ilhan Food Allergy Foundation, AnaphylaxiStop, the Charles and Sylvia Viertel Medical Research Foundation, the Victorian Government’s Operational Infrastructure Support Program, and the NHMRC Centre for Food and Allergy Research.
Conflicts of interest: A. J. Lowe reports grants from the National Health and Medical Research Council during the conduct of the study. M. L. K. Tang is on the Nestle Medical Advisory Board Oceania and the Danone Nutricia Global Scientific Advisory Board; received consultancy fees from Deerfield Consulting, GLG consulting, and Bayer; is employed by and has stock/employee stock options from ProTA Therapeutics; received payment for lectures from Danone Nutricia, Abbott Australia, and Nestle Health Sciences; receives royalties from Wilkinson Publishing; has a patent through Murdoch Children's Research Institute. Her institution received grants from the National Health and Medical Research Council Australia and patents from ProTA Therapeutics for other works. K. J. Allen personally received consultancy fees from ThermoFisher, and is on the Before Brands Scientific Advisory Board. The rest of the authors declare that they have no relevant conflicts of interest.